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INTRODUCTION 
 
Marrow adipose tissue (MAT) accumulation and the 
associated marrow lipotoxicity has been suggested as a 
major cause of bone and red marrow volume decline in 
humans and animals [1–5]. There is evidence that MAT-
associated lipotoxicity impairs osteoblast function and 
survival, driving osteoblast towards a pro-apoptotic/ 
pro-adipogenic phenotype, potentially resulting in  
 
osteoporosis [1–4, 6–8]. MAT accumulation, which 
occurs at the expense of bone and hematopoietic bone 
marrow (HBM) [1], is associated with decreased bone 
formation at the proximity of MAT [9], and declined 
bone mechanical strength [8]. 
 
It has previously been shown that lifelong diets (starting 
at the young age and continuing till the end of life) 
supplemented with fish oil (FO) and borage oil (both rich 
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ABSTRACT 
 
Purpose: Marrow adipose tissue (MAT) expansion and associated lipotoxicity are important drivers of age-
related bone loss and hematopoietic bone marrow (HBM) atrophy. Fish oil and borage oil (rich in ω3 fatty acids) 
can partially prevent aged-related bone loss in SAMP8 mice. However, whether preservation of bone mass in 
this progeria model is associated with MAT volumes remains unknown. 
Results: MAT volume fraction (MAT%) showed a negative association with hematopoietic bone marrow 
(HBM%;r=-0.836, p<0.001) and bone (bone%;r=-0.344, p=0.013) volume fractions.  
Adjusting for multiple comparisons, bone% was higher and MAT% was lower in Fish oil (FO)-supplemented 
groups vs. controls (p<0.001). HBM% did not differ significantly between the four groups. However, in the 
group supplemented with FO, HBM comprised higher fractions and MAT constituted lower fractions of total 
marrow vs. controls (p<0.001). 
Conclusion: Feeding FO-enriched diet prevented age-related bone and HBM loss, by reducing MAT expansion. 
Our results further emphasize on the role(s) of MAT expansion in bone and HBM atrophy. 
Methods: SAMP8 mice (n>9 /group) were allocated into 4 categories and fed a control ration, FO-, sunflower oil 
(SFO)- and borage oil-enriched diets for lifetime. Femurs were scanned using microcomputed tomography (µCT) 
and bone, MAT, and HBM volumes were determined using an image analysis software. 
 
www.aging-us.com 7939 AGING 
in ω3 [n-3] fatty acids) can partially curtail age-related 
bone loss in SAMP8 mice (a progeria animal model),  
that interestingly coincided with decreased levels of 
inflammatory markers [10]. However, it is unknown 
whether preservation of bone mass in this progeria model 
is accompanied by reduced MAT volume.  
 
To study the possible roles of MAT in the reported bone 
mass preservation associated with the supplementation 
of fatty acids we measured bone, MAT and HBM in the 
femoral bones of SAMP8 mice. We hypothesized that 
higher bone volume seen in feeding fatty acids in the 
SAMP8 mice is associated with low MAT and high 
HBM volumes. 
 
RESULTS 
 
Of a total 53 mice in 4 groups, 10 were controls, 20 
received FO, 11 received Sun flower oil (SFO) and 12 
received borage oil supplements. 
 
Overall MAT volume (including all groups) showed a 
strong negative association with HBM (r=-0.836, 
p<0.001), with the strongest association observed within 
SFO group (r=-0.949; p<0.001), followed by FO  
(r=-0.782; p<0.001), control (r=-0.758; p=0.011) and 
borage oil (r=-0.678; p=0.015) cohorts (Figure 1). There 
was an overall negative association between MAT and 
bone volume (r=-0.344, p=0.013), with associations 
being stronger in the control group (r=-0.586, p=0.075). 
None of the groups receiving fatty acid supplements 
showed significant associations between bone and MAT 
volumes (r=-0.225 to 0.332; p=0.337 to 0.482 for FO, 
SFO and borage oil groups respectively; Figure 1). 
 
Despite higher bone% and HBM% and lower MAT% 
values of FO group compared to all other groups, after 
adjusting for multiple comparisons the differences did 
not reach significance (Table 1, and Figure 2). In 
addition, FO group had significantly (p<0.001) higher 
bone volume fraction and lower MAT% compared to 
controls (Table 1). 
 
In addition, marrow ratio of HBM was highest and 
MAT was lowest in the FO group compared to all other 
groups. After adjusting for multiple comparisons, the 
differences remained significant against controls 
(p≤0.001; Table 1). 
 
DISCUSSION 
 
In this study, FO prevented age-related bone and 
hematopoietic marrow loss by preventing the expansion 
of MAT. Lifelong supplementation of fatty acids 
possibly impeded the degree of negative associations of 
MAT against bone. 
The findings of this study confirm the previous reports 
of the higher bone mineral density of SAMP8 mice fed 
FO - and borage oil to some degree [10]. However, as 
the most important finding, our results suggest possible 
roles that MAT expansion plays in both bone and HBM 
volume decline in this model; and importantly, the 
ability of ω3 fatty acids (abundant in FO) to hinder 
MAT expansion and prevent the associated bone and 
HBM loss. 
 
The core rationale for selecting 3 types of fatty acid 
treatment groups was to elucidate whether and how the 
ω3 vs ω6 fatty acids affect bone and marrow health; and 
whether the composition of ω3 supplements plays a 
role. As per Table 2, the most important difference 
between the effective FO-enriched diet versus less/non-
effective other diets was significantly lower ω6/ω3 ratio 
and presence of 20:5 n−3 fatty acids in fish oil (vs. none 
in other diets; Table 2). 
 
 
 
Figure 1. Associations of total tissue volume percentages 
of marrow adipose tissue (%MAT) vs hematopoietic bone 
marrow (%HBM, upper panel) and %bone (lower panel) 
in the four test diet groups. 
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Table 1. Presented are median and IQR. 
Factor 
Control (C)  
(n=10) 
Fish oil (FO)  
group (n=20) 
Sunflower oil 
(SFO) group 
(n=11) 
Borage oil (B) 
group (n=12) 
Overall  
p-value 
Pair-wise comparisons p-values 
C 
vs 
FO 
C 
vs 
SFO 
C 
vs 
B 
FO 
vs 
SFO 
FO 
vs 
B 
SFO 
vs 
B 
MAT% 32.7 (29.4, 36.6) 20.5 (17.6, 22.6) 22.0 (12.0, 30.6) 24.6 (20.8, 28.1) <0.001 <0.001 0.041 0.001 0.59 0.035 0.58 
HBM% 38.0 (35.3, 42.9) 45.3 (38.8, 49.1) 40.7 (32.5, 58.7) 40.8 (37.6, 44.5) 0.12 NA* NA* NA* NA* NA* NA* 
Bone% 27.9 (26.9, 30.6) 35.3 (32.5, 37.7) 32.5 (29.4, 36.7) 34.3 (32.6, 35.8) 0.002 <0.001 0.029 0.01 0.074 0.39 0.3 
HBM/total marrow%, 53.71 (48.8, 58.0) 68.44 (63.3, 74.0) 65.23 (53.6, 83.0) 62.64 (58.1, 68.7) 0.005 <0.001 0.091 0.01 0.53 0.068 0.71 
MAT/total marrow%, 46.29 (42.0, 51.2) 31.56 (26.0, 36.7) 34.77 (17.0, 46.4) 37.36 (31.3, 41.9) 0.005 <0.001 0.091 0.01 0.53 0.068 0.71 
*Inter-group comparisons are not presented due to non-significant overall difference. However, it is worth noting that the mean HBM% 
of fish oil group is at least 12% higher than the other groups. 
Due to adjustments for post-hoc pair-wise multiple comparisons (overall p-value), a p<=0.001 is considered statistically significant. 
 
 
 
 
Figure 2. Hematopoietic bone marrow (HBM%), marrow 
adipose tissue (MAT%) and Bone (Bone%) volume 
fractions (Upper panel) and total marrow volume 
fractions of HBM and MAT compared between four 
nutritional groups (Control; fish oil [FO], sunflower oil 
[SFO] and borage oil groups). Groups with different letter 
markers are significantly different after adjusting for multiple 
comparisons (p<0.001). 
Fat redistribution with aging (from subcutaneous fat into 
muscle, bone marrow and viscera) [6, 7, 11, 12] leads to 
a pathological state where adipocytes lose the ability to 
metabolize triglycerides, respond to hormones (e.g. 
insulin), and produce abnormal endo-, para- and auto-
crine factors (e.g. inflammatory cytokines, leptin, 
adiponectin and resistin) [6, 7, 12]. Also, palmitic acid is 
profusely produced by MAT in human cells in vitro [2] 
and in vivo [13], which is toxic to osteoblasts [4] and 
capable of inducing a pro-inflammatory response within 
marrow [14]. In addition, it has been shown that adipose 
tissue releases only some or none of the expressed IL-6 
and TNFα into the blood stream [15]. The reported lack 
of correlation between MAT and circulating cytokines 
[1] indicates high concentrations of such inflammatory 
mediators in the marrow milieu and auto/paracrine 
activity. The combined effects of inflammation and 
aging (inflammaging) on osteoporosis [16] and anemia 
[17] are well-known, and the above supports the concept 
that MAT can induce direct paracrine lipotoxicity  
and inflammation on bone and HBM tissues and drive 
their atrophy. 
 
Polyunsaturated fatty acids and particularly the ω3 
variety have already been linked to bone health in 
humans and animal models [18, 19]. Interestingly ω3 
fatty acids are associated with preventing endoplasmic 
reticular stress and saturated fatty acid–mediated 
activation of innate immune processes such as 
production of interleukin (IL)-1, IL-6 and TNF, and 
finally bone preservation in ovariectomized mice  
[19–21]. Decreased osteoclastogenesis [19] and 
osteoclastic activity [10] has been shown as an effect of 
ω3 fatty acids supplementation. Considering the ability 
of inflammation [22, 23] and lipotoxicity (particularly 
by MAT) [24, 25] in inducing osteoclastogenesis, all 
evidence point at the potentials of the ω3 fatty acids on 
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Table 2. The fatty acid composition of the four types of diets used in this study (% of total fatty acids). 
Fatty acid carbon 
number 
Standard diet  
(Harlan 2019) 
Sunflower oil based 
diet 
Borage oil enriched 
diet 
Fish oil enriched 
diet 
12:0 0.71 0.00 0.00 0.00 
14:0 0.15 0.05 0.05 0.09 
15:0 0.00 0.00 0.00 0.00 
16:0 11.35 5.11 6.58 5.03 
17:0 0.00 0.02 0.01 0.01 
18:0 3.24 2.75 2.89 2.97 
19:0 0.00 0.00 0.00 0.00 
20:0 0.25 0.19 0.16 0.16 
22:0 0.08 0.24 0.12 0.12 
Total SFA 15.78 8.36 9.81 8.38 
16:1 0.15 0.08 0.14 0.19 
18:1 n−9 23.4 46.89 36.84 37.77 
18:1 n−7 0.00 0.00 0.21 0.52 
20:1 0.54 0.34 1.17 0.73 
22:1 0.05 0.00 0.54 0.00 
24:1 0.00 0.00 0.34 0.00 
Total MUFA 24.14 47.31 39.24 39.21 
18:2 n−6 43.40 54.23 42.04 40.51 
18:3 n−6 0.00 0.00 5.19 0.00 
20:4 n−6 0.00 0.00 0.00 0.31 
Total PUFA ω-6 54.23 42.04 48.59 40.82 
18:3 n−3 5.93 2.29 2.35 2.38 
18:4 n−3 0.01 0.00 0.00 0.52 
20:4 n−3 0.00 0.00 0.00 032 
20:5 n−3 0.00 0.00 0.00 6.35 
21:5 n−3 0.00 0.00 0.00 0.22 
22:5 n−3 0.00 0.00 0.00 0.31 
22:6 n−3 0.00 0.00 0.00 1.50 
Total PUFA ω-3 5.94 2.29 2.35 11.60 
Total PUFA 60.16 44.33 50.94 52.42 
LA/ALA 9.14 18.35 18.46 17.02 
n−6/n−3 9.13 18.35 20.67 3.52 
Total percent 100.00 100.00 100.00 100.00 
Main lipid differences have been highlighted in bold. 
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blocking adipose tissue-induced inflammation, that 
preserves bone mass. In fact, fish oil suppresses  
bone resorption by inhibiting osteoclastogenesis by 
lowering expression of macrophage colony-stimulating 
factor (M-CSF), PU.1, microphthalmia-associated 
transcription factor (MITF), and importantly receptor 
for activation of NFκB (RANK) and RANK ligand 
(RANKL) [26]. 
 
Furthermore, Omega 6 fatty acids may stimulate the 
uptake and depot of extracellular fats within cells [27], 
and ω3 fatty acids may potentially be able to compete 
them and slow down adipogenesis and associated 
lipotoxicity and inflammaging in the marrow milieu. In 
agreement with this hypothesis, feeding mice with a  
FO-rich diet can decrease PPAR-γ gene expression [10] 
in favour of osteoblastogenic and against adipogenic 
commitment of stem cells. Additionally, FO has been 
shown to reduce MAT volume [28] and promote 
hematopoiesis in the bone marrow [29]. However, to our 
knowledge the positive effects of FO on the prevention of 
MAT expansion and its protective effects on both  
bone and HBM - which is of high pathophysiological 
importance for both age-related bone loss and  
anemia - have not been reported before. 
 
Considering the recent reports of very close direct 
interdigitated cellular processes and indirect contact 
between MAT, HBM, osteoblasts and bone lining cells 
with abundant fat vacuoles in-transit from MAT into 
these tissues [30], the chances of both inflammaging 
and lipotoxic effects of MAT on both bone and HBM is 
very likely. 
 
Our finding that prevention of MAT expansion can lead 
to higher ratios of both bone and HBM in this progeria 
model resonates with the findings of Bani Hassan et al. 
[1], who reported that MAT expansion in older men 
accompanies both bone and HBM atrophy, which can 
lead to both osteoporosis and anemia. These findings 
are of significance, as both anemia and osteoporosis are 
interrelated age-associated conditions that are of high 
prevalence in older people, with potentials to cause falls 
and fractures [31–35]. Blocking MAT expansion by 
nutrition, medication or a combination of the two 
approaches, may open new horizons for the prevention 
and treatment of both anemia and osteoporosis. 
 
Other murine models of progeria (e.g. Lamin A- and 
Zmpste24-deficient, Wrn−/−, Terc−/−, PolgAmut/mut, 
Klotho−/−, PolG and XPD strains) also do show 
osteoporosis [36]. Interestingly, PolG and PolgAmut/mut 
strains also show concomitant anemia and osteoporosis 
[36], that akin to SAMP8 model, may imply similar 
MAT lipotoxicity mechanisms inducing both conditions 
in both models. However, whether all other progeria 
mice have both conditions or not has not been reported, 
and should be investigated case by case. 
 
Unlike other reports [19, 37], we did not find evidence 
on the negative effects of ω6 fatty acids (SFO group) on 
bone, which agrees with the observation that ω6 fatty 
acids had no incremental effects on MAT either; that is 
also in agreement with previous reports of no difference 
in the bone mineral density of sunflower oil fed mice vs 
controls [10]. Albeit, the potentials of ω6 fatty acids to 
affect bone health is complex, and depends on their 
constituents (e.g. linoleic to linolenic acid ratios) or the 
ratios of ω3/ω6 [38]. 
 
Major strengths of this study are the longitudinal nature 
of the experiments that continued for the expected 
lifetime of the mice; however, we could not determine 
bone, MAT and HBM volumes at the beginning. We 
used a recently validated non-invasive method to 
quantify MAT in situ and analyzed a large number of 
CTs (~100 slices per femur) to cover both trabecular 
and cortical zones. Albeit, MAT variations may affect 
the measurements of bone density in single energy CT 
[39], but visual checking of the images were 
confirmatory of the reliability of the image analysis 
results. We did not measure the degree of fat infiltration 
into bone compartments (trabecular vs cortical), but 
based on our image analyses (Figure 3), both 
components, as well as HBM are impacted by fat 
infiltration. Future studies will greatly benefit from 
inclusion of other regions of interest (e.g. vertebral 
bodies), that would assist in clarifying which regions 
and component(s) of bone (trabecular or cortical) is 
affected most by MAT infiltration. 
 
 
 
Figure 3. Screen shots of the tagged images of the distal 
femora of SAMP8 mice fed fish oil supplemented (upper 
panel) and control (lower panel) diets. Parasagittal (A and B) 
and coronal/frontal (C and D) plane sections: (E–J) (yellow) 
dotted lines represent the cross-sectional planes that images  
(E–J) display. Those fed fish oil-enriched diet appear to have 
higher bone (blue), hematopoietic marrow (red) and lower 
marrow adipose tissue (green) compared to controls. 
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In conclusion, this study provides further evidence on 
the possible roles of MAT expansion in the progression 
of age-related bone loss and anemia via the lipotoxic 
effects of MAT on bone and HBM in aging mice. 
Further molecular studies are required to investigate the 
crosstalk between tissues and the mechanisms that 
MAT affects both tissues. 
 
MATERIALS AND METHODS 
 
Ethics 
 
All animal procedures were approved by an animal 
welfare committee and were conducted in accordance 
with the National Research Council's guidelines for the 
care and use of laboratory animals. Animals were 
housed in the animal laboratory of the INRA Research 
Center for Human Nutrition. They were housed in a 
controlled environment (12:12 h light/dark cycle,  
20–22 °C, 50–60% relative humidity, 5 mice per cage 
with free access to water). The weaned puppies were 
delivered 1 month before study for acclimatization and 
were provided with free access to a standard growth diet 
for a month. At the end of the study the mice were 
euthanized by IP injection of lethal dose of sodium 
pentobarbital (0.1 ml/gr BW; CEVA Santé Animale, 
Libourne, France); and tissues were harvested, frozen 
and stocked prior to investigation. 
 
Animals 
 
One-month-old female senescence accelerated mouse-
prone 8 (SAMP8) were obtained from INRA-Dijon 
(UMR INRA-CNRS-Université de Bourgogne - Centre 
des Sciences du Goût et de l’Alimentation (CSGA) 
Dijon, France). The animals were housed in standard 
plastic cages as per ethical committee guidelines. After 
acclimatization, mice were provided with free access to 
a standard growth diet for a month. Animals were 
randomly divided in different groups and assigned to 
different diets for ten months ad libitum. Diet 
enrichment did not modify daily food intake 
significantly. To avoid a dramatic increase in SAMP8 
mortality (usually at 12 months) of age [40], the duration 
of study was limited to ten months. Twenty femora and 
their µCT scans were available per group. Only intact 
bones were imaged and only images without artefacts 
were included in the study. Consequently, n=10, 20, 11 
and 12 samples were analyzed for control, FO, SFO and 
borage oil groups, respectively. 
 
Diets 
 
Diets were purchased from INRA (Jouy-en-Josas, France) 
or Harlan (Ganat, France). All diets were adjusted to be 
approximately isocaloric (Δb5%). The mice were fed 
either a standard growth diet (Harlan Teklad Global 
2019), or a sunflower oil (SFO) enriched diet that 
modulates the fatty acid composition in favour of ω6 
(Table 3). Borage oil and fish oil were used to test the 
effect of a γ-linolenic acid (18:3 ω6; GLA) enrichment or 
to reduce the ω6/ω3 ratio by providing eicosapentaenoic 
acid (20:5 ω3; EPA) and docosahexaenoic (22:6 ω3; 
DHA) respectively. 
 
Imaging and tissue volume quantification 
 
Frozen femora were stripped of soft tissues and 
scanned using eXplore CT 120 µCT scanner (GE 
Healthcare, Canada). Acquisition consisted of 360 
views acquired in 1° increments collected in one full 
gantry rotation, with 20 ms exposure/view. X-ray tube 
was set at 100 kV and 50 mA. CT images were 
reconstructed using a modified cone-beam algorithm 
with an isotropic voxel of 45 µm. One hundred µCT 
slices distal femora were analyzed per sample; and 
bone volume fraction, HBM% and MAT% were 
quantified as follows (Figure 1). 
 
µCT images were saved in DICOM format. All CT 
slices within the region of interest were analysed by a 
single blinded observer using Slice-O-Matic® 
(Tomovision, Montreal, Canada), previously validated 
for the measurement of various tissue volumes in 
different species [1, 41–43]. CT Hounsfield values for 
bone, MAT and HBM tissues were calculated. We used 
protocols previously validated in animals to quantify 
yellow/red marrow and bone using a single energy CT 
(MicroCT) and image analysis using Slice-O-Matic 
software [43]. Previous publications on the tissue 
thresholds were consulted, and final threshold ranges 
used for quantification of these parameters were further 
refined visually, using an image histogram [43–47]. 
Thus, the following resultant CT number thresholds 
were applied: MAT ≤450; HBM 451-1900; and bone 
≥1901 Hounsfield units (Figure 3). 
 
Ratios of tissue volumes/total tissue volume (i.e. 
bone%, HBM% and MAT%) and ratios of HBM/total 
marrow% and MAT/total marrow% volumes were 
calculated. 
 
Statistics 
 
Data are presented as median and interquartile range. 
Scatter plots were visually inspected to confirm linear 
relationship between variables and Pearson’s correlation 
coefficient is reported. Between group comparisons 
were performed using Kruskal-Wallis test with post hoc 
rank sum tests for pairwise comparisons with p values 
adjusted using Bonferroni procedure. Analyses were 
performed using Stata 15.1 (StataCorp. 2017. Stata 
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Table 3. Formulations of the diets given to for study groups. 
Ingredient (g/100 g diet) Standard diet (Harlan 2019) 
Sunflower oil based 
diet 
Borage oil enriched 
diet 
Fish oil 
enriched diet 
Wheat starch 55.24 59.14 56.79 56.79 
Casein 19.00 19.20 19.20 19.20 
Sucrose  4.16 4.16 4.16 4.16 
Fiber (cellulose) 3.60 3.50 3.50 3.50 
DL methionine 3.30 0.30 0.30 0.30 
Choline bitartrate 0.20 0.20 0.20 0.20 
Mineral mix  3.50 2.50 2.50 2.50 
Vitamin mix  1.00 1.00 1.00 1.00 
Sunflower oil  0.00 5.45 5.62 6.73 
Canola oil  0.00 2.73 3.37 3.37 
Borage oil  0.00 0.00 2.79 0.00 
Fish oil  0.00 0.00 0.00 1.68 
Oleisol oil  0.00 1.82 0.57 0.57 
Soybean oil  10.00 0.00 0.00 0.00 
Energy (cal)  420 428 440 440 
From I.N.R.A. (Jouy en Josas, France); casein (Union des caséinerie, Surgères, France), cornstarch (Cerestar, Saint-Maur, France), 
cellulose (Durieux, Marne la Vallée, France), oil (Bailly, Aulnay sous Bois, France), vitamin mixture (Roche, Neuilly sur Seine, 
France), mineral mixture (Prolabo, Fontenay sous bois, France), DL-methionine and choline bitartrate (Jerafrance, Jeufosse, France). 
 
Statistical Software: Release 15. College Station, TX: 
StataCorp LLC). Significance was set to p≤0.05; and for 
multiple comparisons p was set to ≤0.001. 
 
Abbreviations 
 
MAT: Marrow adipose tissue; HBM: hematopoietic 
bone marrow; FO: fish oil; SFO: sunflower oil; µCT: 
microcomputed tomography; IL: interleukin. 
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